| |
|
|
1st Australasian Metabolomics Symposium and Workshop, Auckland, New Zealand
05 July 2009 - 07 July 2009
As a post-genomics tool, metabolomics is a young and vibrant field of science. Novel techniques for acquiring and analysing data from metabolomic analysis continue to emerge that are useful for a variety of biological studies.
|
Metabomeeting 2009, Norwich, UK
05 July 2009 - 08 July 2009
The fifth meeting in the Metabomeeting conference series, focuses on providing a forum for new and experienced researchers in metabolomics to meet and discuss all aspects of its research, development and application.
|
Target Discovery World Congress, South San Francisco, CA, USA
04 August 2009 - 05 August 2009
Target Discovery World Congress will be a meeting focusing on the research looking to find new potential drugs for development. The topics will include presentations on the latest in screening platforms and new methods such as those in High Content and Label-Free Screening and will also focus on the work being done looking for new drug targets in some of the major protein families including Ion Channels, GPCRs, Protein Kinases, Nuclear Receptors and the Ubiquitin Pathway.
|
Molecular Diagnostics World Congress, South San Franscisco, CA, USA
06 August 2009 - 07 August 2009
Welcome to the 2nd Molecular Diagnostics World Congress, this year's event will take place at the South San Francisco Conference Center.
|
| |
|
|
SYBR® Green I as a biomarker for schizophrenia
Islamic Azad University of Tonekabon
The purpose of this study were to examine if the mRNA of the peripheral dopamine receptor is changed in schizophrenia patients. 50 Naive patients were enrolled. After extracting RNA from white blood cells, cDNA is synthesized. After doing the quantitative Real-time PCR, expression of D3 receptors in healthy persons and patients were compared. Results of this examinations reveals that expression of D3 receptor is increased in compared with controls sample.
|
Microfluidic PCR device for diagnostic pathogen detection
Molecular Medicine Unit
In this work a microfluidic cyclic flow PCR device is presented, which is capable of replicating the bacterial genomic DNA sequence of the 16S ribosomal RNA. The standard laboratory processing time of 3 h could be decreased to 60 min with the microfluidic reactor without loosing PCR efficiency. Integrating an optical fluorescence detector for dsDNA measurement would evolve this device into a micro total analysis system.
|
Knowledge of personal energy requirements in college students
University of Nevada, Las Vegas
This study explored whether university students were able to estimate their energy requirements within a range of calories equal to predicted Estimated Energy Requirements (EER) two standard deviations. Students significantly underestimated their EER by 700 calories (p<.001). Fewer males than expected were able to estimate energy requirements as compared to females, 41.3% vs. 20.6%, ?2 (1) = 7.236, p=.007.
|
|
|
|
|
|
|
Detection of NADH and NADPH with the Omega’s High Speed, Full UV/Vis Absorbance Spectrometer
BMG LABTECH
NAD+, NADH as well as NADP+, NADPH have been known to play vital roles in energy metabolism, antioxidation, and reductive biosynthesis. Changes in these systems can be monitored using absorbance spectroscopy. NADH and NADPH absorb light at 340 nm, whereas NAD+ and NADP+ do not. The FLUOstar, POLARstar and SPECTROstar Omega microplate readers from BMG LABTECH all have a UV/Vis spectrometer that can measure any absorbance range from 220-850 nm.
|
High-Throughput Method for Dynamic Measurements of Cellular Viability Using a FLUOstar OPTIMA
BMG LABTECH
We show that the propidium iodide (PI) assay performed on the FLUOstar OPTIMA from BMG LABTECH is a very useful tool for monitoring neuronal viability. It allows a complete analysis of the dynamics of the response to a specific substance.
Numerous parameters, including lag times and rates of death can be assessed using this PI method. The FLUOstar OPTIMA is a flexible microplate reader able to record PI fluorescence over very long periods.
|
|
|
|
Multiplexed Diagnostics 2009 Market Report
Published March 2009
Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.
|
|
|